Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|December 1, 1994
Fatal pneumococcal infections following allogeneic bone marrow transplantK Rege, J Mehta, J Treleaven, et al.
Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.
British Journal of Cancer|March 1, 1990
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical responseJ A Maitland, B C Millar, J B Bell, et al.
Bone Marrow Transplantation|February 2, 1997
Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte countsJ Mehta, R Powles, S Singhal, et al.
Bone Marrow Transplantation|October 1, 1995
Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factorsJ Mehta, R Powles, S Singhal, et al.
Lancet (London, England)|December 8, 1990
Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trialR Powles, C Smith, S Milan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Bone Marrow Transplantation|April 15, 2008
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patientsB Sirohi, R Powles, J Treleaven, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescueR Powles, N Raje, D Cunningham, et al.
Leukemia & Lymphoma|May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapyR Powles, N Raje, C Horton, et al.
Pageof 19